Skip to main content
. 2023 Oct;12(3):458–464. doi: 10.61186/rbmb.12.3.458

Table 2.

The prevalence of MTHFR mutation in ALL cases and its association with control group.

MTHFR mutation Responses Case (50) Control (50) p value
Count % Count %
Detection Yes 12 24.0 0 0 0.001*
No 38 76.0 50 100

The prevalence of MTHFR mutation among cancer patents is 24.0%.

*

p value ≤ 0.05.